誉衡药业

- 002437

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2020  2019  2018  2017  2016  2015  2014  2013  2012  2011  2010 
誉衡药业(002437) 利润表
单位:万元
报表日期2020-09-302020-06-302020-03-312019-12-312019-09-30
一、营业总收入221,453.38140,503.6258,101.99505,385.99397,693.19
营业收入221,453.38140,503.6258,101.99505,385.99397,693.19
二、营业总成本223,199.70142,815.9761,508.58477,923.89362,415.81
营业成本59,852.4340,613.5618,638.97134,679.01106,567.24
营业税金及附加2,782.881,986.64624.936,626.344,987.97
销售费用129,286.4680,144.8531,843.43268,710.57209,596.39
管理费用18,326.3312,445.776,546.9335,663.0722,442.71
财务费用6,544.174,139.772,315.6113,666.0211,012.50
研发费用6,407.443,485.391,538.7118,578.887,809.00
资产减值损失----------
公允价值变动收益576.67913.65-96.591,461.42-339.60
投资收益79,253.4879,273.2079,431.85-1,630.60-309.94
其中:对联营企业和合营企业的投资收益-740.26-508.46---2,207.89-788.48
汇兑收益----------
三、营业利润82,693.8681,624.2178,317.30-247,254.7137,294.60
加:营业外收入55.2922.523.61679.90427.17
减:营业外支出1,254.271,180.99543.9313,838.70329.96
其中:非流动资产处置损失----------
四、利润总额81,494.8980,465.7477,776.99-260,413.5237,391.80
减:所得税费用14,920.5712,954.7911,700.415,080.305,991.62
五、净利润66,574.3267,510.9566,076.58-265,493.8131,400.18
归属于母公司所有者的净利润65,769.1566,900.9765,860.03-266,177.3331,031.45
少数股东损益805.17609.98216.55683.52368.73
六、每股收益
基本每股收益(元/股)0.29920.30440.2996-1.21090.1412
稀释每股收益(元/股)0.29920.30440.2996-1.21090.1412
七、其他综合收益-9,960.15-9,651.66220.87-17,043.671,189.37
八、综合收益总额56,614.1757,859.2966,297.45-282,537.4832,589.55
归属于母公司所有者的综合收益总额55,809.0057,249.3166,080.89-283,221.0032,220.82
归属于少数股东的综合收益总额805.17609.98216.55683.52368.73
下载全部历史数据到excel中 返回页顶